It should, however, be emphasized that the CD4+CD25high T cell subset in MS consists of a mixture of highly activated effector cells and regulatory T cells, and functional studies are needed to substantiate a possible regulatory effect of CD4+CD25high T cells expressing CD137 in MS [13]. The gene discussed is TNFRSF9; the disease is myeloid sarcoma.